Gene · 4821
NIH grants1,452
NIH grants whose papers are about the gene, through NIH's grant-paper links.
401 to 420 of 1,452
Download this page as JSON| Grant | Title | NKX2-2 papers | Newest fiscal year |
|---|---|---|---|
| P41EB015922 | Laboratory of Neuro Imaging Resource (LONIR) | 1 | 2022 |
| P42ES010337 | Harnessing Technological Innovation and Community-Engaged Implementation Science to Optimize COVID-19 Testing for Women and Children in Underserved Communities | 1 | 2022 |
| P50CA062924 | SPORE in Gastrointestinal Cancers | 1 | 2022 |
| R01AG060504 | Mechanisms of Growth Factor Responsiveness in the Aging Auditory System | 1 | 2022 |
| R01AI073755 | Antibody-based Protection against Flavivirses | 1 | 2022 |
| R01AI136758 | Cytotoxic immunoconjugates to deplete persistent HIV reservoirs | 1 | 2022 |
| R01CA213138 | CD25-mediated feedback control of BCR-signaling and its oncogenic mimics | 1 | 2022 |
| R01CA218545 | Novel approach to attenuate small cell lung cancer growth and metastasis | 1 | 2022 |
| R01CA226983 | Directing the metabolic fate of CAR T cells | 1 | 2022 |
| R01CA227156 | Identification of genomic drivers of brain metastases in lung adenocarcinoma | 1 | 2022 |
| R01CA227737 | BRAVE hydrogels for interrogating cell-matrix interactions in pancreatic desmoplasia | 1 | 2022 |
| R01DC016409 | Function of LOXHD1 in mechanosensory hair cells | 1 | 2022 |
| R01DK108817 | Discovering genetic and hormonal mechanisms underlying diabetes risk from flies to humans | 1 | 2022 |
| R01DK114650 | Diabetes risk variants affecting transcription factor-regulated cellular networks | 1 | 2022 |
| R01DK116904 | Novel Selective Type II kinase Inhibitors to treat Diabetes | 1 | 2022 |
| R01DK122160 | Pathways and critical regulators of early beta-cell dysfunction in type 1 diabetes | 1 | 2022 |
| R01EB028532 | Integration of systems and synthetic biology to advance development of human tissues ex vivo | 1 | 2022 |
| R01GM112696 | lncRNAs and Anesthetic-Induced Developmental Neurotoxicity | 1 | 2022 |
| R01HD095520 | Biomechanics of Neural Tube Development using Brillouin-OCT Multimodality | 1 | 2022 |
| R01HG010741 | Quantifying the genetic diversity of human regulatory element activity | 1 | 2022 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4821/grants?page=21